Form 4: Rocket Pharmaceuticals Director Transfers Shares to Irrevocable Trust
SEC Form 4 Filing
Director David P. Southwell transferred shares of Rocket Pharmaceuticals common stock to an irrevocable trust on May 2, 2024.
Summary
- On May 2, 2024, David P. Southwell, a director of Rocket Pharmaceuticals, transferred 113,124 shares of common stock directly and 59,716 shares indirectly to The David P. Southwell Irrevocable Trust Dtd 04/14/2024.
- The transfer was a gift, with no funds exchanged and no sale of shares occurring.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding a share transfer. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This transaction is a routine disclosure of insider activity and doesn't necessarily indicate a change in the company's prospects or management's confidence.
Stakeholder Impact
- The transfer of shares to a trust may have implications for the reporting person's ownership structure, but it is unlikely to have a direct impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 04/14/2024 | Date of The David P. Southwell Irrevocable Trust |
| 05/02/2024 | Date of the share transfer transaction |
| 05/20/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.